Context Therapeutics Inc. (CNTX)
Latest CNTX Insider Trades
Andy Pasternak - DirectorGrant or award45,000 sh- Jennifer Evans Stacey - DirectorGrant or award45,000 sh
- Linda West - DirectorGrant or award
About Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
- PHILADELPHIA, PA
- 15
- 2021
- XNAS
https://www.contexttherapeutics.comSEC filings for CNTX on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 270,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
CNTX Insider Transactions (Form 4)
1010 Form 4 filings on record, the earliest from Feb 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andy Pasternak - Director | Grant or award | Stock Option (right to buy) |
Recent CNTX Form 8-K Filings
5CNTX Insider Trading - FAQ
What is the latest insider trade for CNTX?
Context Therapeutics Inc. (CNTX) had 6 insider filings in the last 90 days, with the most recent on 2026-06-26. The full record for CNTX runs to 10 Form 4 filings, the earliest from 2026-02-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CNTX stock?
No insider purchases of CNTX were filed in the last 90 days.
How many insiders are selling CNTX stock?
No insider sales of CNTX were filed in the last 90 days.
Where can I see CNTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks CNTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CNTX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add CNTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Andy Pasternak view on EDGAR
- - Jennifer Evans Stacey view on EDGAR
- - Linda West view on EDGAR
- - Karen L. Smith view on EDGAR
- - Luke Nathaniel Walker view on EDGAR
- - Philip W. Kantoff view on EDGAR
- - Alex C. Levit view on EDGAR
- - Jennifer Lynn Minai-Azary view on EDGAR
- - Karen Deborah Chagin view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track CNTX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
